What employers need to know about Zepbound's expanded use in obstructive sleep apnea.
Health professionals who treat patients with diabetes report three advantages of continuous glucose monitoring when compared to a traditional glucose meter.
Health care spending is projected to rise 8% in 2025, driven by increased use of GLP-1 drugs for diabetes and obesity.
Patient-centered diabetes program drives significant A1C reduction in just 6 months.
How do you offer the care employees need while controlling skyrocketing costs? The good news? It can be done.
Knowledge to Make Informed Benefit Choice
Learn how you can be proactive with diabetes management.
Are Other GLP-1 Uses on the Horizon?
Advance Overall Health and Lower Risks
A Guide to Weight Loss Medications for Benefits Brokers and Advisors
Discover benefits and trade-offs of covering GLP-1 drugs for weight loss and smart strategies for diabetes management.
Resources to Get the Most Effective Diabetes Medications for the Lowest Cost